Benzinga | Jan 27, 2022 05:05AM EST

Jefferies Upgrades Cross Country Healthcare to Buy, Raises Price Target to $27

Jefferies analyst Brian Tanquilut upgrades Cross Country Healthcare (NASDAQ:CCRN) from Hold to Buy and raises the price target from $18 to $27.